Health
New drug could improve life expectancy and quality for pancreatic cancer patients – Medical Xpress
The Sheffield researchers founded the spin-out Modulus Oncology with a team of experienced biotech entrepreneurs to fast-track the drug into clinical testing within two years.
The Sheffield researchers founded the spin-out Modulus Oncology with a team of experienced biotech entrepreneurs to fast-track the drug into clinical testing within two years.
A new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer and relapsed breast cancer, has been invented by scientists at the University of Sheffield.
The researchers founded the spin-out company Modulus Oncology, along with a team of experienced biotech …
-
Business23 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General23 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General22 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting
-
General24 hours agoTroops critically injured in Washington shooting named as FBI launch terror probe
